- Home
- Pathology Industry
- Elan Corporation Market and Forecasts, May 2013
Industries
Top countries
Publication dates
All regions
data types
- All
- Company Data (290)
- Country Data (24)
- Industry Data
Elan Corporation Market and Forecasts, May 2013
You might be interested in: clinical trial, alzheimer's disease, biotechnology, more »
country reports
» Download Public Reports
1-3 of 3 reports for Elan Corporation
Pharmaceutical Production and Trade Statistics
- Industry report
- March 2011
- 16 pages
- by Corporation
... Inc. Invega sustenna in collaboration with elan corporation, plc 6 7 j&j leads the pharmaceutical industry in u.S. Sales generated from 2009-10 product launches rank company ($mm) 1 johnson ...
- Industries: Pathology
Pharmaceutical in Japan and China : Innovation and Technology Trends
- Industry report
- January 2011
- 45 pages
- by Corporation
... Invega sustenna /xeplion technology licensed from elan corporation, plc; risperdal consta developed in collaboration with alkermes, inc.; Nucynta Co-developed with grunenthal gmbh; fulranumab ...
Pharmaceutical in The United States : Innovation and Technology Trends
- Industry report
- June 2012
- 191 pages
- by Market Research Publisher
... It is approved. Tysabri is marketed and distributed by biogen idec inc. And elan corporation, plc. For full prescribing information, including boxed warning and important safety information, and more information ...
- Industries: Pathology
- Countries: United States
Reportlinker.com © Copyright 2013. All rights reserved.
